QuickView for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=1D75C74D5C77A9BAC3E0BBC789397CA4;jsessionid=C855386F3FC95269E723E7516712C4E6;jsessionid=FDB427644414B04AA39E61D5A47DB8BD;jsessionid=DF0BE80AF895D67586D160C20EA44219;jsessionid=7060A3E3B5520395A790C3D99B68DE3F;jsessionid=69169CE8072FF6F54811C60B350B4EA2;jsessionid=624A51D737BB93C621C62C80415F0AE5;jsessionid=0037D45A5F24ECBBEB3BBEDBE3032545;jsessionid=EF5E533DE4C4490A32CCF6A93FE33B60 (gene)

1. AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistan…
2. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Mat…
3. A chemical compound inhibiting the Aha1-Hsp90 chaperone complex.
4. Cooperative Nucleotide Binding in Hsp90 and Its Regulation by Aha1.
5. A Split Renilla Luciferase Complementation Assay for the Evaluation of Hsp90/Aha1 Complex Disruptors…

There were no clinical trials for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=1D75C74D5C77A9BAC3E0BBC789397CA4;jsessionid=C855386F3FC95269E723E7516712C4E6;jsessionid=FDB427644414B04AA39E61D5A47DB8BD;jsessionid=DF0BE80AF895D67586D160C20EA44219;jsessionid=7060A3E3B5520395A790C3D99B68DE3F;jsessionid=69169CE8072FF6F54811C60B350B4EA2;jsessionid=624A51D737BB93C621C62C80415F0AE5;jsessionid=0037D45A5F24ECBBEB3BBEDBE3032545;jsessionid=EF5E533DE4C4490A32CCF6A93FE33B60